Signal from the log
Bridge to Life, Ltd.
110 M$ · Series C · United States · Medtech
Bridge to Life lève 110 M$ pour imposer la perfusion hypothermique oxygénée comme standard de la transplantation hépatique, une technique qui conserve le greffon en le perfusant au lieu de le refroidir sur glace.
Spotted
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 110 M$
- Stage
- Series C
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Led by Soleus Capital , with Lauxera Capital Partners , Soleus Capital Credit Opportunities Fund
Provenance
Source prnewswire,pulse2
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.